Type-1 Diabetes is an autoimmune health condition where sufferer’s body tends to attack and ruin body’s natural insulin producing mechanism as it harms the beta cells in the pancreas. The beta cells are believed to have a major role in insulin manufacturing therefore any person living with diabetes type 1 fails to produce insulin.

An analysis of available medical data has suggested that type 1 diabetes accounts for around 15% of all diabetes cases and tends to affect people during their young ages, probably less than 40. It is a severe health condition as compared to type 2 diabetes, which is often believed as an outcome of unhealthy lifestyle, as its sufferer cannot survive without regular dose of exogenous insulin. In some cases, experts suggest a pancreas transplant in order to restore the body’s natural insulin producing mechanism. Its sufferers need to examine their blood sugar levels frequently with the help of a glucose meter.

Meanwhile, the US Food and Drug Administration has released guidance for scientists and device manufacturers looking forward for the approval of artificial pancreas. Experts have claimed that the device will surely help people with type 1 diabetes for controlling their blood sugar levels.

“It also appears that the draft guidance lays out a rapid timetable to move from inpatient trials to outpatient trials to prove the AP's safety and efficacy, and if that turns out to be the case it is good news”, said the President and Chief Executive Officer of the Juvenile Diabetes Research Foundation, Jeffrey Brewer. In addition, the expert has also notified that the initial reviews of the draft AP guidance have clearly depicted that the FDA is following a responsible attitude with a consideration to the recommendations of leading clinicians as well as researchers in the type 1 diabetes field.